ALLISON CROSBY: Open Payments
NPI 1265143291 · NEW ALBANY, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,158 in 74 payments from 17 companies in 2025. Trend: 2023 $13 · 2024 $56 · 2025 $1,158
Food & beverage: $1,146Education: $12
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 23 | $326 |
| ABBVIE INC. | 15 | $164 |
| Otsuka America Pharmaceutical, Inc. | 7 | $122 |
| E.R. Squibb & Sons, L.L.C. | 5 | $104 |
| Alkermes, Inc. | 5 | $99 |
| Axsome Therapeutics, Inc. | 3 | $66 |
| Neurocrine BioSciences, Inc. | 3 | $57 |
| Lundbeck LLC | 3 | $49 |
| Collegium Pharmaceutical, Inc. | 2 | $29 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $20 |
Products named: CAPLYTA, REXULTI, VRAYLAR, COBENFY, ARISTADA, Auvelity, INGREZZA, Jornay PM.
Industry payments across OH — which companies pay providers there.
